Cargando…
Trabectedin for inoperable or recurrent soft tissue sarcoma in adult patients: a retrospective cohort study
BACKGROUND: Trabectedin is an antineoplastic agent used for patients with soft tissue sarcoma (STS) who fail standard-of-care treatment. Real-world data of its performance is scarce. This study evaluates the safety and effectiveness of trabectedin for patients with advanced STS who were treated at a...
Autores principales: | Angarita, Fernando A., Cannell, Amanda J., Abdul Razak, Albiruni R., Dickson, Brendan C., Blackstein, Martin E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4719676/ https://www.ncbi.nlm.nih.gov/pubmed/26786213 http://dx.doi.org/10.1186/s12885-016-2054-2 |
Ejemplares similares
-
Trabectedin in Soft Tissue Sarcomas
por: Petek, Bradley J., et al.
Publicado: (2015) -
Trabectedin for soft tissue sarcoma
Publicado: (2021) -
The Role of Trabectedin in Soft Tissue Sarcoma
por: Nakamura, Tomoki, et al.
Publicado: (2022) -
Role of trabectedin in the treatment of soft tissue sarcoma
por: Christinat, Alexandre, et al.
Publicado: (2009) -
The value of trabectedin in the treatment of soft tissue sarcoma
por: Nakamura, Tomoki, et al.
Publicado: (2016)